Emisphere Technologies, Inc. is a commercial stage pharmaceutical and drug delivery company in the United States. The company is headquartered in Roseland, New Jersey.
| Revenue (TTM) | $1.04M |
| Gross Profit (TTM) | -305,000 |
| EBITDA | $-6.21M |
| Operating Margin | -596.00% |
| Return on Equity | 0.00% |
| Return on Assets | -43.30% |
| Revenue/Share (TTM) | $0.02 |
| Book Value | $-2.55 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | 457.16 |
| EV/Revenue | 540.14 |
| EV/EBITDA | 59.40 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -40.50% |
| Shares Outstanding | $60.85M |
| Float | $42.37M |
| % Insiders | 0.00% |
| % Institutions | 0.09% |
Volatility is currently expanding